Peripheral Vascular Devices | Market Insights | Europe (Supplemental) | 2024
The European PV device market will grow modestly over the forecast period, driven by increasing adoption of drug-eluting products as more clinical evidence for these technologies emerges, rising procedure volumes for iliac and lower limb indications, and the increasing adoption of endovascular techniques over surgical intervention. However, revenue growth will be limited to some extent by increasing price competition and ongoing cost constraints coupled with unfavorable reimbursement policies.
This Medtech 360 Report provides high-level market metrics for PV devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2032.
